跳至主要内容
临床试验/CTRI/2021/04/033206
CTRI/2021/04/033206已完成不适用

Evaluation of Skin Safety of 3 test products for Primary Skin Irritation Using Skin Irritation Test (Patch Test in Humans)IS 4011:2018 Guidelines.

Lyka Labs Limited1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年3月5日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Evaluation of cutaneous tolerance by dermatological scoring of skin reactions using Draize scale

研究概览

简要总结

VISIT 1: Patch application

VISIT 2 (24 hrs): Patches was removed.

VISIT 3 (48 hrs): Clinical examination and scoring of test area using Draize scale.

VISIT 4 (1 week): If reactions are observed, participants will be called 1 week thereafter.

The Test Products were found to be "Non Irritant" based on IS 4011:2018, Methods of test for safety evaluation of Cosmetics- Third Revision.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Fitzpatrick skin type III to IV.
  • Having apparently healthy skin on test area.
  • Willingness to avoid intense UV exposure on test site (sun or artificial UV), during the course of the study.

排除标准

  • Pregnancy (by history) and lactating women.
  • Scars, excessive terminal hair or tattoo on the studied area.
  • Hypersensitivity, allergy antecedent (to any cosmetic product, raw material, hair dye).

结局指标

主要结局

Evaluation of cutaneous tolerance by dermatological scoring of skin reactions using Draize scale

时间窗: 48 hours

次要结局

未报告次要终点

研究者

申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验